Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.

This summary report looks at approaches like relaxation techniques, selective serotonin reuptake inhibitors (SSRIs), sleep and helpful thinking patterns as part of the different mental health treatments and approaches currently available.

Professor Catherine Harmer, study author, Department of Psychiatry, University of Oxford, said:

 

'Clinical trials show that SSRIs (antidepressants) can help treat anxiety and depression in young people, but they aren’t a solution for everyone. We need to start again when it comes to developing new treatments for young people and we need more research on how treatments work in this age group and how we can make them work better.' 

This publication is released alongside Insights from the Wellcome Global Monitor, a new global survey looking into people's experiences and views on mental health and science. The Global Monitor report highlights that over nine in ten people worldwide (92%) feel mental health is as or more important than physical health for overall wellbeing, with almost half (46%) saying it is more important.

Despite the high value people put on mental health, the survey found that science’s role in understanding and alleviating mental health issues seems unclear to many. Less than a third said science can explain a lot about how feelings and emotions work (27%) or can do a lot to help treat anxiety or depression (31%). In contrast, about half said science can do a lot to help treat infectious diseases (53%) or cancer (49%).  

Professor Miranda Wolpert, Director of Mental Health at Wellcome, said: 

 

'It’s clear that people around the world really value mental health but they don’t see science’s role in improving it. This is perhaps not that surprising, when we still know so little about what works for whom, and why. Science has enormous potential to improve mental health and researchers across the world are working to deepen our understanding and develop new treatment approaches. It might not be easy, but it’s within our grasp. Now is the time to go further and faster to find solutions to the problems faced by all of us.'

Read the full news story and the Wellcome Global Monitor Mental Health report. 

 

Similar stories

Celebrating NDCN at Thomas Willis Day 2026

Our annual event where we join together to celebrate our people and the work of our NDCN over the last year. Nearly 250 staff and students came together for this year's event on Tuesday 16 June at the Mathematical Institute.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship

Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.

New study shows the brain uses brief, slow rhythms to organise how memories are formed, stored, and later recalled

A new study from the University of Oxford and CNRS has shown that the brain uses rhythms for brain cell impulses to coordinate activity across memory-related regions in the brain during learning and help reactivate those experiences afterwards, strengthening what we remember.

Clinical Trial of Ketogenic Therapy for Early Psychosis funded by Baszucki Group

The University Oxford has received £1.17m of funding from Baszucki Group to assess the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P).

The 50th Anniversary of the Oxford Self-harm Monitoring System

Influential and impactful Oxford Self-harm Monitoring System had been in place, and continuously funded, for 50 years.

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease

Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.

Women’s Digital Health Challenge Winners Announced

Dr Fiona Challacombe wins Ripple Women's Digital Health Challenge to develop a clinically-led app for women with Hyperemesis Gravidarum.

Similar stories

Celebrating NDCN at Thomas Willis Day 2026

Our annual event where we join together to celebrate our people and the work of our NDCN over the last year. Nearly 250 staff and students came together for this year's event on Tuesday 16 June at the Mathematical Institute.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship

Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.

New study shows the brain uses brief, slow rhythms to organise how memories are formed, stored, and later recalled

A new study from the University of Oxford and CNRS has shown that the brain uses rhythms for brain cell impulses to coordinate activity across memory-related regions in the brain during learning and help reactivate those experiences afterwards, strengthening what we remember.

Clinical Trial of Ketogenic Therapy for Early Psychosis funded by Baszucki Group

The University Oxford has received £1.17m of funding from Baszucki Group to assess the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P).